Dr. Arthur Moss answers the question: 'Cardiac Resynchronization Device?' — -- Question: What is a cardiac resynchronization device, and is it the same as a pacemaker? Answer:Well, in a way it's ...

BIOTRONIK’s BIO│WOMEN Study Enrolled 474 Patients Across Eight Countries in Europe and IsraelAddressing Critical Gaps as Women Often Remain Undiagnosed and Undertreated in Heart FailureThis ...

Data Demonstrate Clinical and Economic Value of Underutilized Treatment for Heart Failure Patients at American Heart Association's Scientific Sessions 2014 MINNEAPOLIS and CHICAGO - Medtronic, Inc.

Background Studies of cardiac resynchronization therapy in addition to an implantable cardioverter defibrillator in patients with mild to moderate congestive heart failure had not been shown to reduce ...

A meta-analysis by investigators from FDA of three major trials of cardiac resynchronization therapy (CRT) demonstrated that women have a reduced rate of heart failure (HF) and death with CRT at a ...

MINNEAPOLIS - Medtronic, Inc. today announced CE (Conformité Européenne) Mark receipt and the European launch of its newest cardiac resynchronization therapy-pacemaker, Viva® CRT-P. The Viva CRT-P is ...

The loss of coordinated myocardial contraction that occurs as a result of conduction delay is referred to as dyssynchrony and may be evaluated in a number of ways, usually involving echocardiography.

Heart failure is a fatal condition that can put a patient’s life at stake. Heart conditions are caused due to the ill-functioning of the heart due to various internal and lifestyle situations.

Patients in mild heart failure who receive a specialized pacemaker known as cardiac resynchronization therapy with a defibrillator (CRT-D) may live longer than those implanted with a traditional ...

Two new trials have ended up reporting conflicting results regarding the expansion of the indication for cardiac resynchronization therapy (CRT) for patients without a wide QRS interval. The positive ...

New York, USA, Nov. 10, 2022 (GLOBE NEWSWIRE) -- The Global Cardiac Resynchronization Therapy Market is expected to Register an Immense Growth at a CAGR of 6.49% During the Forecast Period (2019–2027) ...